Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Vacuna")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 35667

  • Page / 1427

Export

Selection :

  • and

Consideration of alternative licensing procedures for vaccines for minor species, minor indications and autogenous/autologous productsJONES, P. G. H.Developments in biologicals. 2004, Vol 117, pp 153-158, issn 1424-6074, 6 p.Conference Paper

The WHO Vaccine Trial RegistryROBERTSON, Susan E; MAYANS, Marti Vall; EL-HUSSEINY, Amro et al.Vaccine. 2001, Vol 20, Num 1-2, pp 31-41, issn 0264-410XArticle

Conceptual and experimental approaches to address product safety issues raised by novel cell substrates. DiscussionKRAUSE, P. R; RUBIN, Harry; FRIED, Michael et al.Developments in biologicals. 2001, Vol 106, pp 45-50, issn 1424-6074Conference Paper

Perspectives on sustainable vaccine introductionHINMAN, Alan R.Vaccine. 2013, Vol 31, issn 0264-410X, C8-C9, SUP3Article

Bases des recommandations vaccinales : Vaccination préventive et approches innovantes = Basis for vaccine recommendationsLEVY-BRUHL, Daniel.MS. Médecine sciences. 2007, Vol 23, Num 4, pp 404-408, issn 0767-0974, 5 p.Article

Vaccine use and abuse: A practitioner's viewpointMOORE, G. A.Developments in biologicals. 2004, Vol 117, pp 123-128, issn 1424-6074, 6 p.Conference Paper

Otites récidivantes et vaccinsCOHEN, R.Médecine & enfance. 2003, Vol 23, Num 7, pp 423-428, issn 0291-0233, 4 p.Article

A framework for assessing immunological correlates of protection in vaccine trials. CommentarySADOFF, Jerald C; WITTES, Janet; LI QIN et al.The Journal of infectious diseases. 2007, Vol 196, Num 9, issn 0022-1899, 1279-1281, 1304-1312 [12 p.]Article

Les vaccins, l'état moderne et les sociétés = Vaccines, modern States and societiesMOULIN, Anne Marie.MS. Médecine sciences. 2007, Vol 23, Num 4, pp 428-434, issn 0767-0974, 7 p.Article

Strengths and weaknesses of current polio vaccines: A view from industryANDRE, F. E.Developments in biologicals. 2001, Vol 105, pp 61-66, issn 1424-6074Conference Paper

Progress towards polio eradication: An African perspectiveSCHOUB, B. D; GUMEDE, H. N; BESSELAAR, T. G et al.Developments in biologicals. 2001, Vol 105, pp 9-19, issn 1424-6074Conference Paper

Vaccines and sera through plant biotechnologyKOPROWSKI, Hilary.Vaccine. 2005, Vol 23, Num 15, pp 1757-1763, issn 0264-410X, 7 p.Conference Paper

Characterization of polyvalent allogeneic vaccinesVAN EPPS, D.Developments in biologicals. 2004, Vol 116, pp 79-90, issn 1424-6074, 12 p.Conference Paper

Autogenous vaccines: Industry proposals for procedures and requirementsZÄNKER, S.Developments in biologicals. 2004, Vol 117, pp 27-30, issn 1424-6074, 4 p.Conference Paper

Injectable silicone implants as vaccine delivery vehiclesLOFTHOUSE, S. A; KAJIHARA, M; NAGAHARA, S et al.Vaccine. 2002, Vol 20, Num 13-14, pp 1725-1732, issn 0264-410XArticle

Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adultsNONY, P; GIRARD, P; CHABAUD, S et al.Vaccine. 2001, Vol 19, Num 27, pp 3645-3651, issn 0264-410XArticle

Primum non nocere in vaccinologyBURGIO, G. R; MARSEGLIA, G. L.Vaccine. Supplement. 2001, Vol 20, pp S55-S57, issn 1359-5938Conference Paper

Animal-free culture process for manufacture of viral vaccines : Process validation and regulatory perspectivesPIERARD, I; MARESCHAL, J.-C; GONZE, M.-M et al.Developments in biologicals. 2006, Vol 123, pp 283-290, issn 1424-6074, 8 p.Conference Paper

Harmonization of testing requirements for veterinary vaccinesBELLINZONI, R.Developments in biologicals. 2004, Vol 119, pp 381-382, issn 1424-6074, 2 p.Conference Paper

Use of vaccines for minor species: Minor indicationsSOOS, T.Developments in biologicals. 2004, Vol 117, pp 159-164, issn 1424-6074, 6 p.Conference Paper

Vaccines for minor use/minor species (MUMS) in the European unionMACKAY, D.Developments in biologicals. 2004, Vol 117, pp 141-143, issn 1424-6074, 3 p.Conference Paper

The basis for HIV immunotherapeutic vaccinesPETERS, B. S.Vaccine. 2001, Vol 20, Num 5-6, pp 688-705, issn 0264-410XArticle

Les nouveaux vaccins d'aujourd'hui et de demain: une révolution biotechnologique = New vaccinesREY, M.La Lettre de l'infectiologue. 1989, Vol 4, Num 18, pp 742-748, issn 0296-9009, 6 p.Article

The current challenges for vaccine development : Vaccines and AdjuvantsOYSTON, Petra; ROBINSON, Karen.Journal of medical microbiology. 2012, Vol 61, Num 7, pp 889-894, issn 0022-2615, 6 p.Conference Paper

Diagnostic and Vaccine ChapterWOLFRAM, J. H; KOKANOV, S. K; VERKHOVSKY, O. A et al.Vaccine. Supplement. 2010, Vol 28, Num 5, issn 1359-5938, F49-F53Conference Paper

  • Page / 1427